Explore the latest advances in bladder cancer pathology, diagnosis, and personalized treatment approaches based on International Society of Urological Pathology consensus.
Discover how uPA/PAI-1 and HER2 biomarkers provide complementary information for personalized breast cancer treatment decisions in node-negative patients.